VE VEEV Veeva Systems Loading... : Bullish and Bearish Analyst Opinions

Raymond James lowers its price target on Veeva Systems to 225 dollars, down from 275 dollars.

Veeva Systems reported first quarter revenue of 882.9 million dollars, up 16 percent year over year, and raised fiscal 2027 guidance after exceeding expectations.

VEEV has no debt, $2B buyback, S&P 500 inclusion, and a PE at ~1/3 of historical peak; average analyst target implies 60% upside. These fundamentals, combined with a regulatory moat and upcoming earnings catalyst, suggest the market is mispricing the stock relative to intrinsic value. Long VEEV as a value play with a near-term catalyst (May 27 earnings) and strong operational tailwinds from the Salesforce transition. Earnings miss on May 27; longer-than-expected migration costs; AI disruption or new entrants in clinical trial software; broader tech sell-off.

Veeva operates in the highly regulated life sciences industry, with requirements like an unbroken chain of data custody (audit trail). Its product has deep regulatory integration. These regulatory moats and high switching costs (multi-year, multi-million dollar implementations) protect it from AI-driven displacement and may allow it to leverage AI as a tailwind. It is a durable incumbent in a specialized sector, well-positioned to be a winner in the AI transition. Regulatory changes could lower barriers; AI could eventually navigate complexity faster than expected.

Cramer observes a rotation where "Halo" trades (Industrials) are selling off, while Enterprise Software stocks (Broadcom, ServiceNow, Workday, Adobe, Salesforce, Veeva) are bouncing. The market previously punished these software stocks on the belief that AI (Anthropic/OpenAI) would make them obsolete. Cramer argues this is "absurd" because these companies are fiercely pivoting to integrate AI. The rotation suggests the "death by AI" narrative was priced in too aggressively, creating a rebound opportunity. LONG. Buy the rebound in enterprise software as the "Halo" trade unwinds. Continued oil price spikes could drag down the entire growth sector regardless of the rotation.

"Perhaps because of the stellar earnings from Broadcom... maybe it's because of the bounce that we saw in ServiceNow, Workday, Adobe, Salesforce, and now Veeva Systems... There's been a widespread belief that anything enterprise software can and will be [replaced by AI, but that is reversing]." The market had aggressively sold off enterprise software under the fear that AI would render these SaaS models obsolete. Broadcom's earnings served as a "reality check" catalyst, proving these companies are resilient. This triggers a short-squeeze or value rotation back into high-quality software names that were oversold. Capital is rotating back into software as the "AI death" narrative is disproven by actual earnings. If bond yields spike again, high-duration assets like software could face renewed pressure regardless of the AI narrative.

The stock's positive reaction to its Q4 earnings is likely unsustainable and subject to reversal.

The author suggests that market fears regarding the negative impact of AI on Veeva's business are overblown, implying the stock is likely oversold or undervalued.

Broadcom (AVGO) expects AI chip sales to top $100B by 2027. The Trade Desk (TTD) is in talks to partner with OpenAI for ad delivery. Veeva (VEEV) posted positive results easing AI disruption concerns. These companies are decoupling from the macro war narrative due to idiosyncratic AI growth drivers. The specific revenue forecasts (AVGO) and partnership catalysts (TTD) provide a floor despite broader market volatility. Long these specific tech names as they show relative strength and high growth visibility. General market beta risk if the war causes a total liquidity crunch.